Log in
Enquire now
Trillium Therapeutics

Trillium Therapeutics

Trillium Therapeutics is a biotechnology company developing cancer immunotherapies.

OverviewStructured DataIssuesContributors

Contents

trilliumtherapeutics.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Engineering
Engineering
Healthcare
Healthcare
Immunotherapy
Immunotherapy
Cancer immunotherapy
Cancer immunotherapy
Biomedical engineering
Biomedical engineering
Biopharmaceutical
Biopharmaceutical
Technology
Technology
...
Location
Ontario
Ontario
Mississauga
Mississauga
Canada
Canada
Cambridge, Massachusetts
Cambridge, Massachusetts
Pitchbook URL
pitchbook.com/profiles.../56060-65
Date Incorporated
2004
Number of Employees (Ranges)
11 – 50
Number of Employees
330
Investors
Frazier Healthcare Partners
Frazier Healthcare Partners
Pfizer
Pfizer
Founded Date
2004
Total Funding Amount (USD)
26,000,000
Latest Funding Round Date
May 12, 2011
Latest Funding Type
‌
Venture round
Patents Assigned (Count)
7
Country
Canada
Canada

Other attributes

Company Operating Status
Active

Trillium Therapeutics is a biotechnology company developing cancer immunotherapies that is headquartered in Mississauga, Ontario that was founded in 2004.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Trillium Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.